期刊文献+

荷载肿瘤干细胞抗原的树突状细胞对抗肿瘤免疫反应的影响

Dendritic cells loaded with the cancer stem cells antigen can improve antitumor immune responses
原文传递
导出
摘要 目的 观察荷载肿瘤干细胞抗原的树突状细胞(DC)疫苗对抗肿瘤免疫反应的影响.方法 通过流式细胞分选法筛选肿瘤细胞中乙醛脱氢酶阳性(ALDH+)细胞;利用无血清培养基中细胞克隆球形成实验和皮下成瘤实验,验证所得ALDH+细胞是否具有肿瘤干细胞特性;然后通过冻融裂解法制备肿瘤干细胞抗原;通过酶联免疫吸附试验(ELISA)法检测白细胞介素-12(IL-12)分泌量,乳酸脱氢酶(LDH)释放法检测DC诱导细胞毒性T淋巴细胞(CTL)对普通肿瘤细胞及肿瘤干细胞的杀伤作用.结果 Hepa1-6 ALDH+细胞所占比例为3.27%,B16 ALDH+细胞所占比例为3.40%;所得ALDH+细胞具有肿瘤干细胞特性;肿瘤干细胞抗原与阴性对照组比较,可使DC分泌更多IL-12(P <0.05),能诱导针对普通肿瘤细胞更强的CTL杀伤作用(P<0.05);肿瘤干细胞抗原与各对照组比较,可以诱导针对肿瘤干细胞更强的CTL杀伤作用(P<0.05),尤其效应细胞与靶细胞比值(E∶T)为40∶1时,在Hepa1-6和B16两种细胞株中对肿瘤干细胞杀伤率分别达到(56.5±4.6)%和(60.5±5.5)%.结论 荷载肿瘤干细胞抗原的DC可以促进抗肿瘤免疫反应,诱导针对肿瘤干细胞及肿瘤细胞更强的CTL杀伤作用. Objective To study the effects of administration of the cancer stem cells (CSC) antigen loaded tumor vaccine in mice on antitumor immune.Methods We identified the acetaldehyde dehydrogenase positive (ALDH +) cells by using ALDEFLUOR stem cell identification kit and flow cytometry.Then test whether the ALDH + cells had the characteristics of CSC by tumor clone ball culture experiments and subcutaneous tumor formation experiments.CSC antigens were prepared by repeating freezing and thawing cells.Dendritic cells (DCs) ' interleukin-12 (IL-12) secretion was evaluated by enzyme linked immunosorbent assay (ELISA).The cytotoxic lymphocyte (CTL) activity against normal cancer cells and CSC induced by DCs was tested by LDH cytotoxicity assay.Results The proportion of Hepa1-6 ALDH +cells is 3.27%,the proportion of B16 ALDH + cells is 3.40%.The ALDH + cells were proved with the characteristics of CSC.DCs loaded with CSC antigen could significantly secret more IL-12.DCs loaded with CSC antigen could induce stronger CTL activity against normal cancer cells than control.DCs loaded with CSC antigen could induce stronger CTL activity against CSC,especially when the E∶T ratio was 40∶1,the kill rates were (56.5 ± 4.6) % and (60.5 ± 5.5) % in two cell lines.Conclusion DCs loaded with CSC antigen could induce more effective antitumor immune effects against CSC.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2014年第12期2726-2728,共3页 Chinese Journal of Experimental Surgery
基金 上海市卫生局重点资助项目(20114005)
关键词 肿瘤干细胞 树突状细胞 肿瘤免疫 Cancer stem cells Dendritic cells Antitumor immunity
  • 相关文献

参考文献9

  • 1Nishikawa S,Konno M,Hamabe A,et al.Aldehyde dehydrogenasehigh gastric cancer stem cells are resistant to chemotherapy[J].Int J Oncol,2013,42(4):1437-1442.
  • 2Vogler T,Kriegl L,Horst D,et al.The expression pattern of aldehyde dehydrogenase 1(ALDH1) is an independent prognostic marker for low survival in colorectal tumors[J].Exp Mol Pathol,2012,92(1):111-117.
  • 3曾令成,叶飞,韩林,郭东生,雷霆.乙醛脱氢酶1在脑胶质瘤中的表达[J].中华实验外科杂志,2013,30(9):1794-1795. 被引量:2
  • 4董天庚,牛伟新,洪信强,李文翔,秦新裕.联合激动Toll样受体的树突细胞对小鼠结肠癌生长的影响[J].中华实验外科杂志,2012,29(2):181-183. 被引量:4
  • 5Kalinski P,Muthuswamy R,Urban J.Dendritic cells in cancer immunotherapy:vaccines and combination immunotherapies[J].Expert Rev Vaccines,2013,12(3):285-295.
  • 6Warger T,Osterloh P,Rechtsteiner G,et al.Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo[J].Blood,2006,108(2):544-550.
  • 7Franci C,Zhou J,Jiang Z,et al.Biomarkers of Residual Disease,Disseminated Tumor Cells,and Metastases in the MMTV-PyMT Breast Cancer Model[J].PLoS One,2013,8(3):e58183.
  • 8Fuchs A,Vermi W,Lee JS,et al.Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12-and IL-15vresponsive IFN-γ-producing[J].Immunity,2013,38(4):769-781.
  • 9Sun JC,Pan K,Chen MS,et al.Dendritic cells-mediated CTLs targeting hepatocellular carcinoma stem cells[J].Cancer Biol Ther,2010,10(4):368-375.

二级参考文献20

  • 1Banchereau J, Palucka AK. Dendritic cells as therapeutic vaccines a- gainst cancer. Nat Rev Immunol,2005 ,5 :296-306.
  • 2Rakoff-Nahoum S, Medzhitov R. Toll-like receptors and cancer. Nat Rev Cancer,2009,9:57-63.
  • 3Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in in- nate immune defence. Nat Rev Immunol,2007 ,7 :179-190.
  • 4Whitmore MM, Deveer MJ, Edling A, et al. Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity. Cancer Res,2004,64:5850-5860.
  • 5Clarke P, Mann J, Simpson JF, et al. Mice transgenic for human carci- noembryonic antigen as a model for immunotherapy. Cancer Res, 1995,58:1469-1477.
  • 6Warger T, Osterloh P, Rechtsteiner G, et al. Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superi- or CTL responses in vivo. Blood,2006,108:544-550.
  • 7Ojima T, Iwahashi M, Nakamura M, et al. Successful cancer vaccine therapy for carcinoembryonic antigen (CEA) -expressing colon cancer using genetically modified dendritic cells that express CEA and T helper-type 1 cytokines in CEA transgenic mice. Int J Cancer,2007, 120:585-593.
  • 8Boullart AC, Aarntzen EH, Verdijk P, et al. Maturation of monocyte- derived dendritic cells with Toll-like receptor 3 and 7/8 ligands com- bined with prostaglandin E2 results in high interleukin-12 production and cell migration. Cancer Immunol Immunother, 2008, 57: 1589- 1597.
  • 9Conroy H,Marshall NA, Mills KH. TLR ligand suppression or enhance- ment of Treg cells? A double-edged sword in immunity to tumours. Onco- gene,2008,27 : 168-180.
  • 10Jackson B, Brocker C, Thompson DC, et al. Update on the aldehyde dehydrogenase gene (ALDH) superfamily. Hum Genomics, 2011,5 : 283 -303.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部